Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells.

Sandra Grau-Bartual, Ahmed M Al-Jumaily, Paul M Young, Daniela Traini, Maliheh Ghadiri

Open access · goldAbstract read

In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

0.6field-weighted citation impact, top 33% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

Comparative evaluation of the efficacy of customized maxillary oral appliance with mandibular advancement appliance as a treatment modality for moderate obstructive sleep apnea patients-a randomized controlled trial.Trials · 2023
Trial
Airway-On-A-Chip: Designs and Applications for Lung Repair and Disease.Cells · 2021
Review
Prediction of upper airway dryness and optimal continuous positive airway pressure conditions.Journal of biomechanics · 2020
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sandra Grau-BartualInstitute of Biomedical Technologies, Auckland University of Technology, Auckland, New Zealand.

Ahmed M Al-JumailyInstitute of Biomedical Technologies, Auckland University of Technology, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-9826-0374

Paul M YoungWoolcock Institute of Medical Research, University of Sydney, Sydney, Australia.

Daniela TrainiWoolcock Institute of Medical Research, University of Sydney, Sydney, Australia.ORCID https://orcid.org/0000-0002-7173-017X

Maliheh GhadiriWoolcock Institute of Medical Research, University of Sydney, Sydney, Australia.

The University of Sydney · AUAuckland University of Technology · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Continuous positive airway pressure (CPAP) therapy is the gold standard treatment for obstructive sleep apnoea, which affects millions of people worldwide. However, this therapy normally results in symptoms such as dryness, sneezing, rhinorrhoea, post-nasal drip, nasal congestion and epistaxis in the upper airways. Using bronchial epithelial (Calu-3) and nasal epithelial (RPMI 2650) cells in an

Identifiers

PMID32537464

DOI10.1183/23120541.00327-2019

PMCPMC7276533

OpenAlexW3035639855

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.